Try our beta test site
1 study found for:    of hydroxychloroquine in combination with gemcitabine/abraxane to inhibit autophagy in pancreatic cancer
Show Display Options
Rank Status Study
1 Recruiting A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic Cancer
Conditions: Advanced Adenocarcinoma;   Metastatic Adenocarcinoma
Interventions: Drug: Hydroxychloroquine (HCQ);   Drug: Gemcitabine

Study has passed its completion date and status has not been verified in more than two years.